See the Impact Beem's Blue Light Therapy Has on Your Skin Health!
Part of paid clinical trials in New York, New York.
- Sponsor
- Efforia, Inc
- Study ID
- NCT07298382
- Status
- Recruiting
Conditions
- Skin
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - N/A
- Healthy Volunteers
- Accepted
Interventions
- Blue Light Therapy — DEVICEBlue Light Therapy therapy, combining blue, red, and infrared light, has been backed by studies showing improved skin health and reduced signs of aging. The medical community generally supports light therapy for its non-invasive nature and potential benefits, though results can vary. Social media buzz highlights glowing testimonials, while the general population views it as a promising skincare enhancement with minimal risks. Benefits include improved complexion and reduced acne, with risks being rare and minor, such as temporary redness. Treatment: First 5 Minutes 450nm (Blue) Second 5 Minutes 450nm (Blue) 660nm (Red) 810nm (Infrared) Final 10 Minutes 660nm (Red) 810nm (Infrared)
Study Details
Participants will experience a rejuvenating twice-weekly light therapy journey that blends the power of blue, red, and infrared light. Each 20-minute session flows through three phases: starting with refreshing blue light to awaken and energize, then moving into soothing red light, and finishing with deeply nourishing infrared light. This unique protocol is designed to help unlock healthier-looking skin and boost your natural glow.
Key Dates
- Start date
- Oct 6, 2025
- Status verified
- Nov 2025
- Primary completion
- Oct 6, 2026
- Completion
- Oct 6, 2026
Study Design
- Enrollment
- 100 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- HEALTH_SERVICES_RESEARCH
Arms
- Experimental: Single Arm longitudinal where participants act as their own controlSingle Arm longitudinal where participants act as their own control
Primary Outcome Measure
Comprehensive Weekly Skin Health Self-Assessment [ Time Frame: Baseline through Day 30 (weekly assessments) ]
Central Contacts
- Matthew Amsden(646) 679-2479
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Efforia | New York | New York | 10003 |
Find similar trials in New York, NY
By research site
Related Studies
- Trial of Ixazomib for Kaposi SarcomaPHASE2 · Recruiting · AIDS Malignancy Consortium · San Diego, California
- In Vivo Cross-Modal Imaging of SkinRecruiting · Gabriel Sanchez · Mountain View, California